Page last updated: 2024-12-06

propham

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

propham: minor descriptor (72-85); on-line & Index Medicus search HERBICIDES, CARBAMATE (72-85); RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

propham : A carbamate ester that is the isopropyl ester of phenylcarbamic acid. It is a selective herbicide used for the control of annual grasses and some broad-leaf weeds and is also a growth regulator for control of sprouting in stored potatoes. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID24685
CHEMBL ID1080996
CHEBI ID82035
SCHEMBL ID67344
MeSH IDM0262902

Synonyms (111)

Synonym
isopropyl-n-phenylurethan
usaf d-9
n-phenylcarbamate d'isopropyle
birgin
collavin
ippc
isopropyl n-phenylcarbamate
tuberite
o-isopropyl n-phenylcarbamate
isopropyl phenyl urethane
y 2
tixit
IFK ,
profam
prophame
chem-hoe
inpc
iso.ppc.
n-phenyl isopropyl carbamate
n-phenylcarbamic acid, isopropyl ester
ortho grass killer
carbanilic acid, isopropyl ester
tuberit
isopropyl phenylcarbmate
isopropyl carbanilate
isopropyl carbanilic acid ester
ban-hoe
IFC ,
nsc2105
propham
nsc-2105
wln: 1y1 & ovmr
triherbide
isopropyl-n-phenyl-carbamat
122-42-9
phenylcarbamic acid,1-methylethyl ester
isopropil-n-fenil-carbammato
triherbide-ipc
agermin
isopropyl phenylcarbamate
isopropyl-n-fenyl-carbamaat
beet-kleen
ENAMINE_005910
isopropyl-n-phenyl carbamate
1-methylethyl phenylcarbamate
einecs 204-542-0
caswell no. 510
o-isopropyl n-phenyl carbamate
nsc 2105
rcra waste no. u373
isopropyl-n-fenyl-carbamaat [dutch]
isopropyl-n-phenylcarbamate
premalox
isopropyl-n-phenyl-carbamat [german]
brn 2209666
phenylcarbamic acid, 1-methylethyl ester
isopropylester kyseliny karbanilove [czech]
propham [bsi:iso]
hsdb 602
isopropyl-n-phenylurethan [german]
ai3-14879
n-phenylcarbamate d'isopropyle [french]
isopropil-n-fenil-carbammato [italian]
iso.ppc
prophame [iso-french]
carbamic acid, phenyl-, 1-methylethyl ester
IDI1_008145
NCGC00163998-01
HMS1410M14
propan-2-yl n-phenylcarbamate
CHEMBL1080996
chebi:82035 ,
AKOS001022035
NCGC00163998-02
isopropylester kyseliny karbanilove
y647g714ry ,
unii-y647g714ry
4-12-00-00620 (beilstein handbook reference)
carbamic acid, n-phenyl-, 1-methylethyl ester
C18887
dtxcid70766
cas-122-42-9
dtxsid7020766 ,
NCGC00256576-01
tox21_302973
NCGC00259213-01
tox21_201664
FT-0603327
SCHEMBL67344
propham [hsdb]
1-methylethyl n-phenylcarbamate
propham [mi]
propham [iarc]
propham [iso]
propan-2-yl phenylcarbamate
n-phenyl-o-isopropylurethane
carbamic acid, phenyl, isopropyl ester
carbamate pesticide ipc
isoppc
Z55310382
mfcd00026382
J-004801
propham, pestanal(r), analytical standard
propham, ~99%, crystalline
propham 10 microg/ml in acetonitrile
propham 100 microg/ml in acetonitrile
Q26840767
AS-15559
AMY38459
propham 100 microg/ml in toluene
iso-propyl phenylcarbamate

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Dose-response assays include seed germination and analyses of shoot and root elongation on paper."( Determination of plant resistance to carbamate herbicidal compounds inhibiting cell division and early growth by seed and plantlets bioassays.
Ben Shir, I; Keinan, E; Rubin, B; Shulman, A; Weiss, Y; Wolf, S, 2006
)
0.33
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
herbicideA substance used to destroy plant pests.
plant growth retardantnull
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
carbamate esterAny ester of carbamic acid or its N-substituted derivatives.
benzenesAny benzenoid aromatic compound consisting of the benzene skeleton and its substituted derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (13)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
LuciferasePhotinus pyralis (common eastern firefly)Potency37.79340.007215.758889.3584AID1224835
RAR-related orphan receptor gammaMus musculus (house mouse)Potency38.84150.006038.004119,952.5996AID1159521; AID1159523
AR proteinHomo sapiens (human)Potency0.00220.000221.22318,912.5098AID588515
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency34.65090.001022.650876.6163AID1224838; AID1224839; AID1224893
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency31.46980.003041.611522,387.1992AID1159552; AID1159553; AID1159555
retinoid X nuclear receptor alphaHomo sapiens (human)Potency54.94100.000817.505159.3239AID1159527
pregnane X nuclear receptorHomo sapiens (human)Potency56.87340.005428.02631,258.9301AID1346982; AID720659
estrogen nuclear receptor alphaHomo sapiens (human)Potency32.26400.000229.305416,493.5996AID743069; AID743079; AID743080; AID743091
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency32.96620.001723.839378.1014AID743083
thyroid hormone receptor beta isoform aHomo sapiens (human)Potency0.03160.010039.53711,122.0200AID588547
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency30.70020.000323.4451159.6830AID743065
histone deacetylase 9 isoform 3Homo sapiens (human)Potency26.60100.037617.082361.1927AID1259364; AID1259388
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency54.48270.000627.21521,122.0200AID720636
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (9)

Assay IDTitleYearJournalArticle
AID1347151Optimization of GU AMC qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347169Tertiary RLuc qRT-PCR qHTS assay for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347167Vero cells viability qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347150Optimization screen NINDS AMC qHTS for Zika virus inhibitors: Linked NS2B-NS3 protease assay2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347168HepG2 cells viability qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347149Furin counterscreen qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347155Optimization screen NINDS Rhodamine qHTS for Zika virus inhibitors: Linked NS2B-NS3 protease assay2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID468443Inhibition of human FAAH at 1 uM2009Bioorganic & medicinal chemistry letters, Dec-01, Volume: 19, Issue:23
Mining biologically-active molecules for inhibitors of fatty acid amide hydrolase (FAAH): identification of phenmedipham and amperozide as FAAH inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (24)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (37.50)18.7374
1990's1 (4.17)18.2507
2000's7 (29.17)29.6817
2010's4 (16.67)24.3611
2020's3 (12.50)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 30.19

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index30.19 (24.57)
Research Supply Index3.30 (2.92)
Research Growth Index5.13 (4.65)
Search Engine Demand Index36.71 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (30.19)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other26 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]